Literature DB >> 26248594

Molecular dynamics and functional studies define a hot spot of crystal contacts essential for PcTx1 inhibition of acid-sensing ion channel 1a.

Natalie J Saez1, Evelyne Deplazes1,2, Ben Cristofori-Armstrong1, Irène R Chassagnon1, Xiaozhen Lin, Mehdi Mobli3, Alan E Mark2, Lachlan D Rash1, Glenn F King1,2.   

Abstract

BACKGROUND AND
PURPOSE: The spider-venom peptide PcTx1 is the most potent and selective inhibitor of acid-sensing ion channel (ASIC) 1a. It has centrally acting analgesic activity and is neuroprotective in rodent models of ischaemic stroke. Understanding the molecular details of the PcTx1 : ASIC1a interaction should facilitate development of therapeutically useful ASIC1a modulators. Previously, we showed that several key pharmacophore residues of PcTx1 reside in a dynamic β-hairpin loop; conclusions confirmed by recent crystal structures of the complex formed between PcTx1 and chicken ASIC1 (cASIC1). Numerous peptide : channel contacts were observed in these crystal structures, but it remains unclear which of these are functionally important. EXPERIMENTAL APPROACH: We combined molecular dynamics (MD) simulations of the PcTx1 : cASIC1 complex with mutagenesis of PcTx1 and rat ASIC1a. KEY
RESULTS: Crystal structures of the PcTx1 : cASIC1 complex indicated that 15 PcTx1 residues form a total of 57 pairwise intermolecular contacts (<5 Å) with 32 channel residues. MD simulations, however, suggested that about half of these interactions do not persist in solution. Mutation to alanine of only eight of 15 PcTx1 contact residues substantially altered ASIC1a inhibition by PcTx1. Our data reveal that many of the peptide-channel interactions observed in the PcTx1 : cASIC1 crystal structures are not important for PcTx1 inhibition of rat ASIC1a. CONCLUSIONS AND IMPLICATIONS: We identified the atomic interactions that are critical for PcTx1 inhibition of ASIC1a. Our data highlight the value of combining structural information, MD and functional experiments to obtain detailed insight into the molecular basis of protein : protein interactions.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26248594      PMCID: PMC4621980          DOI: 10.1111/bph.13267

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Identification of a calcium permeable human acid-sensing ion channel 1 transcript variant.

Authors:  Erin N Hoagland; Thomas W Sherwood; Kirsten G Lee; Christopher J Walker; Candice C Askwith
Journal:  J Biol Chem       Date:  2010-10-29       Impact factor: 5.157

3.  The receptor site of the spider toxin PcTx1 on the proton-gated cation channel ASIC1a.

Authors:  Miguel Salinas; Lachlan D Rash; Anne Baron; Gérard Lambeau; Pierre Escoubas; Michel Lazdunski
Journal:  J Physiol       Date:  2005-11-10       Impact factor: 5.182

4.  Very fast empirical prediction and rationalization of protein pKa values.

Authors:  Hui Li; Andrew D Robertson; Jan H Jensen
Journal:  Proteins       Date:  2005-12-01

Review 5.  Anatomy of hot spots in protein interfaces.

Authors:  A A Bogan; K S Thorn
Journal:  J Mol Biol       Date:  1998-07-03       Impact factor: 5.469

6.  A dynamic pharmacophore drives the interaction between Psalmotoxin-1 and the putative drug target acid-sensing ion channel 1a.

Authors:  Natalie J Saez; Mehdi Mobli; Michael Bieri; Irène R Chassagnon; Alpeshkumar K Malde; Roland Gamsjaeger; Alan E Mark; Paul R Gooley; Lachlan D Rash; Glenn F King
Journal:  Mol Pharmacol       Date:  2011-08-08       Impact factor: 4.436

Review 7.  ASICs as therapeutic targets for migraine.

Authors:  Greg Dussor
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

8.  Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach.

Authors:  Julie K Klint; Jennifer J Smith; Irina Vetter; Darshani B Rupasinghe; Sing Yan Er; Sebastian Senff; Volker Herzig; Mehdi Mobli; Richard J Lewis; Frank Bosmans; Glenn F King
Journal:  Br J Pharmacol       Date:  2015-03-04       Impact factor: 8.739

9.  Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH.

Authors:  Jayasankar Jasti; Hiroyasu Furukawa; Eric B Gonzales; Eric Gouaux
Journal:  Nature       Date:  2007-09-20       Impact factor: 49.962

10.  Seizure termination by acidosis depends on ASIC1a.

Authors:  Adam E Ziemann; Mikael K Schnizler; Gregory W Albert; Meryl A Severson; Matthew A Howard; Michael J Welsh; John A Wemmie
Journal:  Nat Neurosci       Date:  2008-06-08       Impact factor: 24.884

View more
  15 in total

1.  Molecular dynamics and functional studies define a hot spot of crystal contacts essential for PcTx1 inhibition of acid-sensing ion channel 1a.

Authors:  Natalie J Saez; Evelyne Deplazes; Ben Cristofori-Armstrong; Irène R Chassagnon; Xiaozhen Lin; Mehdi Mobli; Alan E Mark; Lachlan D Rash; Glenn F King
Journal:  Br J Pharmacol       Date:  2015-09-22       Impact factor: 8.739

2.  Mambalgin-1 Pain-relieving Peptide, Stepwise Solid-phase Synthesis, Crystal Structure, and Functional Domain for Acid-sensing Ion Channel 1a Inhibition.

Authors:  Gilles Mourier; Miguel Salinas; Pascal Kessler; Enrico A Stura; Mathieu Leblanc; Livia Tepshi; Thomas Besson; Sylvie Diochot; Anne Baron; Dominique Douguet; Eric Lingueglia; Denis Servent
Journal:  J Biol Chem       Date:  2015-12-17       Impact factor: 5.157

3.  Mechanism and site of action of big dynorphin on ASIC1a.

Authors:  Christian B Borg; Nina Braun; Stephanie A Heusser; Yasmin Bay; Daniel Weis; Iacopo Galleano; Camilla Lund; Weihua Tian; Linda M Haugaard-Kedström; Eric P Bennett; Timothy Lynagh; Kristian Strømgaard; Jacob Andersen; Stephan A Pless
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-12       Impact factor: 11.205

Review 4.  An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge.

Authors:  Ugo Perricone; Maria Rita Gulotta; Jessica Lombino; Barbara Parrino; Stella Cascioferro; Patrizia Diana; Girolamo Cirrincione; Alessandro Padova
Journal:  Medchemcomm       Date:  2018-04-19       Impact factor: 3.597

Review 5.  Anticancer, antimicrobial, and analgesic activities of spider venoms.

Authors:  Hassan M Akef
Journal:  Toxicol Res (Camb)       Date:  2018-03-08       Impact factor: 3.524

6.  Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a.

Authors:  Irène R Chassagnon; Claudia A McCarthy; Yanni K-Y Chin; Sandy S Pineda; Angelo Keramidas; Mehdi Mobli; Vi Pham; T Michael De Silva; Joseph W Lynch; Robert E Widdop; Lachlan D Rash; Glenn F King
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

7.  Selective inhibition of ASIC1a confers functional and morphological neuroprotection following traumatic spinal cord injury.

Authors:  Liam M Koehn; Natassya M Noor; Qing Dong; Sing-Yan Er; Lachlan D Rash; Glenn F King; Katarzyna M Dziegielewska; Norman R Saunders; Mark D Habgood
Journal:  F1000Res       Date:  2016-07-26

Review 8.  Molecular Simulations of Disulfide-Rich Venom Peptides with Ion Channels and Membranes.

Authors:  Evelyne Deplazes
Journal:  Molecules       Date:  2017-02-27       Impact factor: 4.411

9.  Mutations in the palm domain disrupt modulation of acid-sensing ion channel 1a currents by neuropeptides.

Authors:  Benoîte Bargeton; Justyna Iwaszkiewicz; Gaetano Bonifacio; Sophie Roy; Vincent Zoete; Stephan Kellenberger
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

Review 10.  Animal, Herb, and Microbial Toxins for Structural and Pharmacological Study of Acid-Sensing Ion Channels.

Authors:  Dmitry I Osmakov; Timur A Khasanov; Yaroslav A Andreev; Ekaterina N Lyukmanova; Sergey A Kozlov
Journal:  Front Pharmacol       Date:  2020-07-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.